A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee
about
A randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibilityESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryAntiplatelet agents versus control or anticoagulation for heart failure in sinus rhythmHomocysteine-lowering interventions for preventing cardiovascular eventsAntiplatelet agents for chronic kidney diseaseAntiplatelet agents for chronic kidney diseaseHomocysteine-lowering interventions for preventing cardiovascular eventsAdenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitusAntiplatelet agents and anticoagulants for hypertensionClopidogrel plus aspirin versus aspirin alone for preventing cardiovascular diseaseAntiplatelet agents for intermittent claudicationBeta-adrenergic blockers for perioperative cardiac risk reduction in patients undergoing vascular surgeryClopidogrel plus aspirin versus aspirin alone for preventing cardiovascular diseaseTriflusal for preventing serious vascular events in people at high riskAntiplatelet agents and anticoagulants for hypertensionCollaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsCentral role of the P2Y12 receptor in platelet activationEffects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second StrokesAspirin and extended-release dipyridamole versus clopidogrel for recurrent strokeEpidemiology, classification, and modifiable risk factors of peripheral arterial diseaseResults of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement?Is clopidogrel superior to aspirin in secondary prevention of vascular disease?Antiplatelet and anticoagulant therapy in elective percutaneous coronary interventionP2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cellsPrevalence of antiplatelet therapy in patients with diabetes.Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levelsThe clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423].Current status of high on-treatment platelet reactivity in patients with coronary or peripheral arterial disease: Mechanisms, evaluation and clinical implicationsInternal Iliac Artery Stenosis: Diagnosis and How to Manage it in 2015Peripheral Arterial Disease in Patients with Type 2 Diabetes MellitusComing safely to a stop: a review of platelet activity after cessation of antiplatelet drugsSecondary stroke prevention: challenges and solutionsTIA Management: Should TIA Patients be Admitted? Should TIA Patients Get Combination Antiplatelet Therapy?Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-AnalysisComparative Efficacy and Safety of Different Antiplatelet Agents for Prevention of Major Cardiovascular Events and Leg Amputations in Patients with Peripheral Arterial Disease: A Systematic Review and Network Meta-AnalysisBlood cells: an historical account of the roles of purinergic signallingAntiplatelet therapy for carotid artery stentingDo the Effects of Secondary Prevention of Cardiovascular Events in PAD Patients Differ from Other Atherosclerotic Disease?Treatment and prevention of gastrointestinal bleeding in patients receiving antiplatelet therapyCritical limb ischemia: advanced medical therapy
P2860
Q21144269-C248B90D-749B-41A0-BD09-C12E1999600EQ22241786-5B63A077-6AD2-4BBF-A9B4-C87DD78C0008Q24185800-815C97A1-D9C3-4B34-A499-C577B541BF48Q24186605-4D3B1D67-B94D-4DDE-A503-4EFDFF2C29FAQ24197614-C427E299-8E7E-4C05-9505-00150641187BQ24200752-E508D35C-ED32-47D5-94D5-B982B678C5E9Q24201783-57D100A6-918A-4A32-8FB5-E54C1E04F859Q24203035-D4CB8B7B-9AD2-4E50-A179-CA592CD0D633Q24234617-37F4FA85-3DBA-4889-AB80-072063AED7D5Q24234632-BC340C2F-DAC3-4A00-B445-04A35EE72932Q24235178-8A77B040-6996-4545-A5B4-608FDDB2D159Q24243256-34483E2C-1547-4DB1-B210-64660BA284FEQ24243939-C72E7D8A-E313-4293-A0F7-5902C6CFF77BQ24246399-F57DE360-C391-459D-9E63-B55AF65A3AAFQ24246637-6EC00443-EB41-4765-BD8D-FB61B2102833Q24555072-903636B9-14D9-4BCE-8167-8393314D57A1Q24618777-D4819B88-7C49-48E9-9059-A2547C65EF42Q24645205-F2B123D5-180D-48BE-A39A-1F4B770164A5Q24646522-D414CD8D-1BED-46DE-B519-BF25A4D737CAQ24681271-E1D8FE47-B62E-40E6-BE08-66083880A0C9Q24792611-29B87B9B-C89E-4DB4-826F-3AC9007F20D5Q24792794-5BA15F61-A26C-4AD9-86CD-9F2E0DFEB62FQ24793199-C6AFD640-42B0-4AA6-B7D3-9C4F34CF114EQ24799571-B87F8486-2797-4A4E-9BCF-71F6C54943C0Q24813940-7BD09939-19A8-4546-8DEF-9EDB0F92B651Q24816368-CFA40578-4D7C-4497-AA4E-E4021B6D3CA8Q24816629-9BC20E27-20D3-499B-A83C-58A9D515DF1BQ26771106-C1942347-C630-4F4C-9460-01CF8AFB927FQ26776106-90FBDCC4-8E7C-4BB8-AAE8-00D0EB992D32Q26795374-84DA8B3F-3F47-4F82-B83B-1319B41CCA44Q26795403-107C5643-60A3-4A30-9BFC-9F5906839F04Q26795568-901516B5-E623-4C31-887F-3CF3FA15D9F1Q26796466-3EFC0F37-4EB1-471B-BAC6-FE840D65197FQ26797510-530FDD39-C612-4F19-B444-5BCB13FAE54EQ26798134-628CDEA2-099F-4293-8FE7-299C9EB3EB9EQ26799623-7B83AC05-C635-49FA-BC33-892D080E6D1AQ26852304-632C4487-8FE5-4600-9E19-B7DF0FB500C6Q26852616-822F169C-D5CF-41F5-B106-BEC8025DDF95Q26866350-90B676AF-25D8-40AA-9A93-972200FD5C54Q26995245-7E831079-D7E3-4FF4-80E9-FD69F0752170
P2860
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee
description
1996 nî lūn-bûn
@nan
1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
A randomised, blinded, trial o ...... IE). CAPRIE Steering Committee
@ast
A randomised, blinded, trial o ...... IE). CAPRIE Steering Committee
@en
type
label
A randomised, blinded, trial o ...... IE). CAPRIE Steering Committee
@ast
A randomised, blinded, trial o ...... IE). CAPRIE Steering Committee
@en
prefLabel
A randomised, blinded, trial o ...... IE). CAPRIE Steering Committee
@ast
A randomised, blinded, trial o ...... IE). CAPRIE Steering Committee
@en
P3181
P1433
P1476
A randomised, blinded, trial o ...... IE). CAPRIE Steering Committee
@en
P304
P3181
P356
10.1016/S0140-6736(96)09457-3
P407
P577
1996-11-16T00:00:00Z